These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31073978)

  • 1. PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.
    Luo WY; Xing SQ; Zhu P; Zhang CG; Yang HM; Van Halm-Lutterodt N; Gu L; Zhang H
    Neurotherapeutics; 2019 Jul; 16(3):761-783. PubMed ID: 31073978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model.
    Wang Y; Gu L; Yang HM; Zhang H
    Neurotoxicology; 2021 May; 84():14-29. PubMed ID: 33571554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
    Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
    J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
    Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
    Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
    Xi SS; Bai XX; Gu L; Bao LH; Yang HM; An W; Wang XM; Zhang H
    Pharmacol Res; 2017 Jul; 121():145-157. PubMed ID: 28455267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson's disease model.
    Bai XX; Gu L; Yang HM; Xi SS; Xia N; Zhang S; Zhang H
    Toxicol Lett; 2018 May; 288():71-81. PubMed ID: 29458170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of type 5 metabotropic glutamate receptor promotes the proliferation of rat retinal progenitor cell via activation of the PI-3-K and MAPK signaling pathways.
    Zhang Z; Hu F; Liu Y; Ma B; Chen X; Zhu K; Shi Y; Wei T; Xing Y; Gao Y; Lu H; Liu Y; Kang Q
    Neuroscience; 2016 May; 322():138-51. PubMed ID: 26902516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
    Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
    Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
    Paquet M; Ribeiro FM; Guadagno J; Esseltine JL; Ferguson SS; Cregan SP
    Mol Brain; 2013 Feb; 6():9. PubMed ID: 23406666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
    Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway.
    Chen T; Cao L; Dong W; Luo P; Liu W; Qu Y; Fei Z
    Neurochem Res; 2012 May; 37(5):983-90. PubMed ID: 22228200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.
    Fieblinger T; Sebastianutto I; Alcacer C; Bimpisidis Z; Maslava N; Sandberg S; Engblom D; Cenci MA
    J Neurosci; 2014 Mar; 34(13):4728-40. PubMed ID: 24672017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity.
    Zhu JW; Yuan JF; Yang HM; Wang ST; Zhang CG; Sun LL; Yang H; Zhang H
    Biochimie; 2012 Mar; 94(3):617-27. PubMed ID: 21964032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Parkinson's disease-associated protein alpha-synuclein suppresses tumorigenesis via interaction with mGluR5 and gamma-synuclein in liver cancer.
    Yang HM; Cheng YZ; Hou TZ; Fan JK; Gu L; Zhang JN; Zhang H
    Arch Biochem Biophys; 2023 Aug; 744():109698. PubMed ID: 37487948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.
    Zhu YN; Zuo GJ; Wang Q; Chen XM; Cheng JK; Zhang S
    Int Ophthalmol; 2019 Oct; 39(10):2223-2235. PubMed ID: 30607864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity.
    Sun L; Gu L; Wang S; Yuan J; Yang H; Zhu J; Zhang H
    PLoS One; 2012; 7(3):e32503. PubMed ID: 22442667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
    Huang YY; Zhang Q; Zhang JN; Zhang YN; Gu L; Yang HM; Xia N; Wang XM; Zhang H
    Brain Behav Immun; 2018 Jul; 71():93-107. PubMed ID: 29649522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
    Liu F; Gong X; Zhang G; Marquis K; Reinhart P; Andree TH
    J Neurochem; 2005 Dec; 95(5):1363-72. PubMed ID: 16277616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated mGluR5 induces ER stress and DNA damage by regulating the NMDA receptor subunit NR2B.
    Gu L; Luo WY; Xia N; Zhang JN; Fan JK; Yang HM; Wang MC; Zhang H
    J Biochem; 2022 Mar; 171(3):349-359. PubMed ID: 34908130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.